Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone

[1]  R. Tsonaka,et al.  Half-dose photodynamic therapy versus eplerenone in chronic central serous chorioretinopathy (SPECTRA): a randomized controlled trial. , 2021, American journal of ophthalmology.

[2]  Anju S. Raju,et al.  Eplerenone monotherapy in a rare case of bullous central serous retinopathy with retinal pigment epithelial macro-rip , 2021 .

[3]  J. Chhablani,et al.  Long-term outcomes of half-fluence photodynamic therapy and eplerenone in chronic central serous chorioretinopathy: A comparative study , 2021, European journal of ophthalmology.

[4]  F. Sartini,et al.  Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review , 2020, Pharmaceuticals.

[5]  S. Harding,et al.  Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial , 2020, The Lancet.

[6]  M. Larsen,et al.  Central serous chorioretinopathy: Towards an evidence-based treatment guideline , 2019, Progress in Retinal and Eye Research.

[7]  Grant L. Hom,et al.  Eplerenone for the treatment of chronic central serous chorioretinopathy: 3-year clinical experience , 2019, British Journal of Ophthalmology.

[8]  Vishali Gupta,et al.  An unusual case of multifocal central serous chorioretinopathy with low serum cortisol managed using eplerenone , 2019, Indian journal of ophthalmology.

[9]  Jie Hu,et al.  Photodynamic therapy for bullous retinal detachment: a single-center experience of case series with a 6-month follow-up study , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

[10]  Eva C Ramos-Yau,et al.  SPIRONOLACTONE AS A THERAPEUTIC ALTERNATIVE FOR THE BULLOUS VARIANT OF CENTRAL SEROUS CHORIORETINOPATHY. , 2018, Retinal cases & brief reports.

[11]  Bradley T. Smith,et al.  Exogenous Testosterone Use and Central Serous Chorioretinopathy , 2018 .

[12]  İ. Tuğal-Tutkun,et al.  Atypical Central Serous Chorioretinopathy , 2017, Turkish journal of ophthalmology.

[13]  L. Yannuzzi,et al.  Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging. , 2016, Ophthalmology.

[14]  N. Ohba,et al.  A LONG-TERM FOLLOW-UP STUDY OF SEVERE VARIANT OF CENTRAL SEROUS CHORIORETINOPATHY , 2002, Retina.

[15]  B. Mukesh,et al.  SUBRETINAL FIBROSIS AND NONRHEGMATOGENOUS RETINAL DETACHMENT ASSOCIATED WITH MULTIFOCAL CENTRAL SEROUS CHORIORETINOPATHY , 1998, Retina.